1. Baramova, E & Foidart, JM (1995). Matrix metalloproteinase family. Cell Biol Int 19: 239–242.
2. Barrett, AJ (1995). Classification of peptidases. Methods Enzymol 244: 1–15.
3. Bouchet, C, Spyratos, F, Martin, PM, Hacene, K, Gentile, A & Oglobine, J (1994). Prognostic value of urokinase type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas. Br J Cancer 69: 398–405.
4. Brown, CJ, Rahman, S, Morton, AC, Beauchamp, CL, Bramwell, H & Buttle, DJ (1996). Inhibitors of collagenase but not gelatinase reduce cartilage explant proteolglycan breakdown despite only low levels of matrix metalloproteinase activity. J Clin Pathol: Mol Pathol 49: M331–M339.
5. Brown, PD, Bloxidge, RE, Anderson, E & Howell, A (1993). Expression of activated gelatinase in human invasive breast carcinoma. Clin Exp Metastasis 11: 183–189.